Market Research Report

A quick peek into the report

Flow Cytometry in Oncology and Immunology Market - A Global and Regional Analysis

Focus on Offering, Technology, End User, Type, Application, and Country - Analysis and Forecast, 2022-2032

Some Faq's

Frequently Asked Questions

According to BIS Research, flow cytometry in the field of oncology is utilized for the quantitative detection and measurement of the physical and chemical characteristics of cancerous cells in a given sample. Flow cytometry is majorly used for hematological malignancies to identify malignant cell types by detecting cell surface antigens, which offer critical information regarding the stage of maturation and phenotypical heterogeneity.  

The global flow cytometry in oncology and immunology market has witnessed major developments by key players operating in the market, such as business expansions, partnerships, collaborations, regulatory and legal activities, funding activities, product launches, and acquisitions and mergers. According to BIS Research analysis, most of the companies preferred new offerings as a strategy to further increase their growth in the global flow cytometry in oncology and immunology market. Companies such as Becton, Dickinson and Company, DiaSorin S.p.A., Bio-Rad Laboratories, and Agilent Technologies, Inc. have majorly adopted new offerings as their preferred strategy.

A new entrant can focus on developing flow cytometry products for application in solid tumors. 

The following can be considered some of the USPs of the report:

•    Impact of COVID-19 on the global flow cytometry in oncology and immunology market, including the detailed analysis of pre-COVID-19 and during the COVID-19 scenario, along with the future impact of COVID-19 pandemic on the market
•    Extensive product benchmarking of the top players (including established and emerging players) to offer a holistic view of the global flow cytometry in oncology and immunology market product landscape
•    Product mapping analysis 
•    Cancer incidence at the country level
•    Market share analysis based on product portfolios, recent developments, and regional spread of the key players
•    Reimbursement scenario and regulatory framework 

The companies developing, manufacturing, and commercializing products for flow cytometry in oncology and immunology should buy this report.

Similar Product

You may also like

Global Flow Cytometry in Oncology Market
Published Year: 2021

Global Flow Cytometry in Oncology Market: Focus on Product Type, Technology, Type of Cancer, Applica

The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over...